-
2022-501417-31-00
5
High-risk Resected Melanoma
-
2023-503522-40-00
4
Atopic Dermatitis
-
2024-520302-19-00
4
Atopic dermatitis
-
2025-523820-26-00
5
Growth Hormone Deficiency (GHD)
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-507427-28-00
5
seasonal allergic rhinitis and/or rhinoconjunctivitis
-
2023-509659-15-00
6
Patients with ovarian cancer, fallopian tube cancer, peritoneal carcin
-
2024-511054-50-00
10
HIV-1 Infection
-
2024-516376-15-00
11
periprocedural anticoagulant treatment in patients treated with TEER o
-
2024-516382-37-00
6
Atrial fibrillation
-
2024-516384-93-00
6
Atrial Fibrillation
-
2024-516589-13-00
5
Acute coronary syndrome
-
2024-516805-22-00
5
Major Depressive Disorder
-
2024-517753-27-01
5
moderate or severe activity of systemic lupus erythematosus (SLE)
-
2024-518275-64-00
4
Diffuse large B-cell lymphomas (DLBCL, Diffuse large B-cell lymphoma)
-
2024-518420-80-00
5
Primary infection prophylaxis for secondary immunodeficiency (SID) in
-
2024-518759-45-00
5
Children primary nephropathy IgA
-
2024-518835-13-00
5
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar),
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-520117-50-00
4
Atopic Dermatitis
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520565-51-00
5
small cell lung cancer